Mov Disord Vol 35, Suppl 1 Archives - Page 13 of 149 - MDS Abstracts

MDS Virtual Congress 2020
A Patient with Gait Disturbance Caused by Parkinson’s Disease: A Case Report
M. Park, SS. Park, S.H Lee, C.Y Kim, I.W Choi, I.C Chae, H.R Yoo (Daejeon, Republic of Korea)
Objective: It is well known that mental simulation of movement in the brain can facilitate motor rehabilitation. Our hypothesis is: can a direct, sequential stimulation…
MDS Virtual Congress 2020
Longitudinal clinical and imaging characteristics of non-manifest LRRK2 carriers: The PPMI cohort
T. Simuni, A. Siderowf, M. Brumm, C. Caspell, H. Cho, C. Coffey, T. Foroud, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, K. Marek, p. PPMI Investigators (Chicago, IL, USA)
Objective: To examine longitudinal change in the clinical characteristics of non-manifesting LRRK2 mutation carriers (NMCs) compared to healthy controls (HC) in the Parkinson’s Progression Markers…
MDS Virtual Congress 2020
Prevalence and Characteristics of Postural Deformities in Thai Patients with Parkinson’s Disease
T. Wangthumrong, C. Pongmala, Y. Pitakpatapee, J. Srikajon, M. Vichutavate, P. Srivanitchpoom (Bangkok, Thailand)
Objective: We aimed to investigate the prevalence, clinical characteristics and quality of life (QoL) in Thai Parkinson's disease (PD) patients with postural deformities (PostD) and…
MDS Virtual Congress 2020
Deep brain stimulation lead position impact on parkinsonian non-motor symptoms
J. Bardoň, S. Kurčová, M. Chudáčková, P. Otruba, D. Krahulík, M. Nevrlý, P. Kaňovský, J. Zapletalová, J. Valošek, P. Hluštík (Olomouc, Czech Republic)
Objective: This study evaluated the direct impact of localization of deep brain stimulation electrodes active contact within the different parts of subthalamic nucleus on improvement…
MDS Virtual Congress 2020
Correlation between location of active contacts and weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease
K. Eguchi, I. Yabe, S. Shirai, M. Matsushima, T. Kano, K. Yamazaki, S. Hamauchi, T. Sasamori, K. Hirata, T. Seki, M. Kitagawa, M. Otsuki, T. Shiga, K. Hokin, H. Sasaki (Sapporo, Japan)
Objective: Objective: The aim of this study was to evaluate the correlation between the location of active contacts and weight gain after subthalamic nucleus deep…
MDS Virtual Congress 2020
Characterization of the pattern of daily motor fluctuations in Parkinson’s disease patients based on home diaries
R. Hauser, W. Poewe, J. Ferreira, A. Lees, G. Liang, M. Fonseca, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Tampa, FL, USA)
Objective: Home diary-based representation of patients’ daily motor status. Background: Parkinson’s disease (PD) patients are often in their best clinical state when attending medical appointments.…
MDS Virtual Congress 2020
Effect of opicapone and entacapone on daily pattern of motor fluctuations in Parkinson’s disease patients
A. Lees, O. Rascol, J. Ferreira, O. Klepitskaya, M. Fonseca, D. Magalhães, J.F Rocha, P. Soares-da-Silva (London, United Kingdom)
Objective: To evaluate the effect of opicapone (OPC) 50 mg versus entacapone (ENT) on daily pattern of motor fluctuations. Background: OPC, a once-daily catechol-O-methyltransferase inhibitor,…
MDS Virtual Congress 2020
Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson’s disease: A prospective analysis of Thai Apomorphine Registry
O. Phokaewvarangkul, K. Boonpang, R. Bhidayasiri (Bangkok, Thailand)
Objective: To evaluate a reduction of LED in PD patients who achieve satisfactory motor control with long-term continuous subcutaneous apomorphine infusion (CSAI) Background: Apomorphine is…
MDS Virtual Congress 2020
12-month therapeutic evaluation of l-dopa carbidopa ascorbic acid solution (LCAS) in a cohort of Advanced Parkinson’s disease in a North-Indian tertiary care hospital
K. Shukla, N. Sawal (Chandigarh, India)
Objective: To prescribe LCAS to Parkinson’s disease(PD) patients whose symptoms were not adequately controlled on tablet l-dopa and compare the UPDRS-(I,II,III,IV) ON & OFF on…
MDS Virtual Congress 2020
Evaluation of Advanced Parkinson’s Patients Using Levodopa Carbidopa Instestinal Gel: Results of the Aegean Region of Turkey
O. Yilmaz Kusbeci, A. Acarer, B. Donmez Colakoglu, I. Inci, R. Cakmur, A. Akyol, Z. Colakoglu (Izmir, Turkey)
Objective: The aim of the present study was to evaluate the outcome of LCIG treatment in advanced PD in Aegean Region of Turkey. Background: Levodopa/carbidopa…